Insider Brief
High Q Technologies is using a quantum-enabled electron paramagnetic resonance (EPR) platform to help accelerate drug discovery for Alzheimer’s disease and other neurodegenerative disorders by mapping protein motion in greater detail.
The company’s Fathom system uses quantum sensors to capture multiple protein configurations simultaneously, providing researchers with a more complete view of how proteins behave and interact with potential drug candidates.
High Q has partnered with contract research organization Creative Biostructure to expand global access to the technology, with support from Canadian government programs, Quantum Valley Investments and the University of Waterloo’s Transformative Quantum Technologies accelerator.
Photo by Shubham Dhage on Unsplash
